Cornelia L. Dekker mostly deals with Immunology, Vaccination, Virology, Antibody and Immune system. In her study, Cornelia L. Dekker carries out multidisciplinary Immunology and Placebo research. Her Vaccination research includes themes of Proinflammatory cytokine, Virus, Neutralizing antibody and Chemokine.
Her Virology study combines topics from a wide range of disciplines, such as T cell, Immunization and Immunoglobulin G. Her Immunization study incorporates themes from Live attenuated influenza vaccine and Influenza vaccine. Her work carried out in the field of Immune system brings together such families of science as Young adult, Chromatin, Cell and Cell biology.
Cornelia L. Dekker mainly focuses on Immunology, Vaccination, Virology, Immune system and Antibody. Her study in Influenza A virus, T cell, Antigen, Immunogenicity and Titer is carried out as part of her Immunology studies. In Immunogenicity, Cornelia L. Dekker works on issues like Adjuvant, which are connected to MF59.
The various areas that Cornelia L. Dekker examines in her Vaccination study include Adverse effect, Immunization and Pediatrics. Her studies link CD8 with Virology. Her Immune system research integrates issues from Apoptosis, Cell and Cytokine.
Immune system, Influenza vaccine, Antibody, Immunology and Vaccination are her primary areas of study. Her Immune system research is multidisciplinary, incorporating elements of Young adult, Natural killer cell and Receptor. Her Influenza vaccine study also includes
The Antibody study combines topics in areas such as Kawasaki disease, Internal medicine, Randomized controlled trial and Infliximab. Her research integrates issues of Vascular function and Mass cytometry in her study of Immunology. Her Vaccination research incorporates themes from Orthomyxoviridae, Influenza A virus, Hemagglutination assay and Nasal administration.
Her main research concerns Immune system, Antibody Repertoire, Antibody, Mass cytometry and Disease. Her Immune system study combines topics in areas such as Young adult, Multivariate analysis and Proportional hazards model. Cornelia L. Dekker has researched Antibody Repertoire in several fields, including Somatic evolution in cancer, B cell and Phylogenetic tree.
Her study in Antibody is interdisciplinary in nature, drawing from both Evolutionary biology, Effector, Cell biology, Clone and Vaccination. Her research in Mass cytometry intersects with topics in Cancer cell, Natural killer cell, Receptor and Immunology. She studies Antigen, a branch of Immunology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Variation in the Human Immune System Is Largely Driven by Non-Heritable Influences
Petter Brodin;Petter Brodin;Vladimir Jojic;Tianxiang Gao;Sanchita Bhattacharya.
Recombinant Glycoprotein Vaccine for the Prevention of Genital HSV-2 Infection Two Randomized Controlled Trials
Lawrence Corey;Andria G.M. Langenberg;Rhoda Ashley;Rose E. Sekulovich.
Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry
Amir Horowitz;Dara M. Strauss-Albee;Michael Leipold;Jessica Kubo.
Science Translational Medicine (2013)
Systems analysis of sex differences reveals an immunosuppressive role for testosterone in the response to influenza vaccination
David Furman;Boris P. Hejblum;Noah Simon;Vladimir Jojic.
Proceedings of the National Academy of Sciences of the United States of America (2014)
Cellular Immune Responses in Children and Adults Receiving Inactivated or Live Attenuated Influenza Vaccines
Xiao-Song He;Tyson H. Holmes;Caiqiu Zhang;Kutubuddin Mahmood.
Journal of Virology (2006)
Lineage Structure of the Human Antibody Repertoire in Response to Influenza Vaccination
Ning Jiang;Jiankui He;Joshua A. Weinstein;Joshua A. Weinstein;Lolita Penland.
Science Translational Medicine (2013)
Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes.
S.E Straus;B Savarese;P.R Krause;R.G Kost.
The Lancet (1994)
Influence of Prior Influenza Vaccination on Antibody and B-Cell Responses
Sanae Sasaki;Xiao-Song He;Xiao-Song He;Tyson H. Holmes;Cornelia L. Dekker.
PLOS ONE (2008)
A Recombinant Glycoprotein Vaccine for Herpes Simplex Type 2: Safety and Efficacy
Andria G. M. Langenberg;Rae Lyn Burke;Suzanne F. Adair;Rose Sekulovich.
Annals of Internal Medicine (1995)
Effects of Adjuvants on the Safety and Immunogenicity of an Avian Influenza H5N1 Vaccine in Adults
David I. Bernstein;Kathryn M. Edwards;Cornelia L. Dekker;Robert Belshe.
The Journal of Infectious Diseases (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: